APPLICATION
ANDA090141
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-22
LATEST ACTION
2023-02-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
TADALAFILPrescription
TADALAFIL 20MG · TABLET · ORAL
TADALAFILPrescription
TADALAFIL 5MG · TABLET · ORAL
TADALAFILPrescription
TADALAFIL 10MG · TABLET · ORAL
TADALAFILPrescription
TADALAFIL 2.5MG · TABLET · ORAL
Approval history
2023-02-15Labeling · Supplement 7 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.